NCBiotech News

North Carolina Central University will soon make it easier for area biopharmaceutical companies to fill job vacancies with qualified employees via online courses offered through NCCU’s Biomanufacturing Research Institute and Technology Enterprise (BRITE).

Grifols, a global biotherapeutics company with major operations in North Carolina, has received approval from the U.S. Food and Drug Administration for a new formulation of GamaSTAN, its medicine for treating patients who’ve been exposed to the hepatitis A or measles viruses.

A novel drug candidate aimed at preventing and treating hereditary angioedema (HAE) – a recurrent and severe swelling disorder – has shown positive results in a clinical trial, according to its Durham-based developer, BioCryst

Research Triangle Park-based CertriRx recently started doing business as Verinetics. But the young company hasn’t changed its focus, or the speed with which it is making inroads in anti-counterfeiting technology.

Ken Hoffman, a veteran of the clinical diagnostics industry, was living and working in Boston some 20 years ago when he chose to move his new startup company, Cygnus Technologies, to the small North Carolina coastal community of Southport to enjoy a different lifestyle. It led to big-time success and growth.

As the co-founder, CEO and board chair of Javara Inc., a privately funded Winston-Salem clinical research services firm, Jennifer Byrne is convinced her company’s newly minted “Integrated Research Organization" platform offers a more-effective solution to the immense challenges of patient enrollment in clinical trials.

As algae blooms fed by chemical fertilizer runoff from farms and lawns contaminate more waterways every year, Mirimichi Green Express is rooting its future in high-end eco-sensitive plant-growing products in the Southeastern North Carolina community of Castle Hayne, near Wilmington.

Durham-based 410 Medical, developer of a new medical device for treating critically ill patients, has raised $3.1 million in new financing to commercialize the product.

A simple idea became a life-changing one for a young Duke physician assistant who never planned to do anything but practice medicine. Now Shawn Gage is not only an inventor, but an entrepreneur too.

Aerie Pharmaceuticals, an ophthalmic pharmaceutical company based in Durham, has reported positive clinical results for Rhopressa, its once-daily eye drop approved for the reduction of elevated eye pressure, a cause of glaucoma.

Hernan Navarro, Ph.D., retired chief scientist for RTI International’s Center for Drug Discovery, has returned to the workplace to direct the Biomedical Research Institute and Technology Enterprise (BRITE) at North Carolina Central University in Durham. 

Raleigh-based Eva Garland Consulting (EGC) is on the prestigious Inc. 5000 list of the country’s fastest-growing private companies.

North Carolina is home to six of the top 10 community colleges in the nation, according to SmartAsset, an online site aimed at helping people make smart financial decisions.

Funding from the North Carolina Biotechnology Center has enabled doctors in Western N.C. to use genetic testing to prescribe more-effective medicines for their patients. It’s part of a larger center-led effort to promote the statewide growth and development of precision health.

BARDA's Division of Research, Innovation and Ventures, or DRIVe, has simplified the process companies and researchers can use to apply for grants to fund disruptive solutions to health security threats.